Stock LGVN LONGEVERON INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Longeveron Inc.

Equities

LGVN

US54303L2034

Market Closed - Nasdaq
Other stock markets
 21:00:00 01/05/2024 BST 		5-day change 1st Jan Change
1.74 USD +1.75% Intraday chart for Longeveron Inc. -4.40% -87.21%
04-30 Longeveron Files Prospectus for Secondary Offering MT
04-15 Top Premarket Gainers MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Longeveron Files Prospectus for Secondary Offering
MT
Longeveron to Present at the Planet MicroCap Showcase
AQ
Longeveron Raises a Total of $11.4 Million in Gross Proceeds from Warrant Exercise Offering and Public Offering
AQ
Longeveron Announces Exercise of Warrants for $6.2 Million Gross Proceeds
AQ
Longeveron's CLEAR MIND Randomized Phase 2a Clinical Trial Evaluating Lomecel-B in Mild Alzheimer's Disease Accepted for Featured Research Session Oral Presentation
AQ
Longeveron’s CLEAR MIND Randomized Phase 2a Clinical Trial Evaluating Lomecel-B™ in Mild Alzheimer’s Disease Accepted for Featured Research Session Oral Presentation at the 2024 Alzheimer’s Association International Conference (AAIC)
AQ
Top Premarket Gainers
MT
Longeveron Announces Closing of $5.2 Million Public Offering
AQ
Longeveron Announces Pricing of $5.25 Million Public Offering
AQ
Longeveron Issues Letter to Shareholders Highlighting Corporate Strategy, Clinical Pipeline and 2024 Key Priorities and Goals
AQ
Top Premarket Gainers
MT
Longeveron to Effect 1-for-10 Reverse Stock Split
MT
Longeveron Announces 1-for-10 Reverse Stock Split
AQ
Transcript : Longeveron Inc., 2023 Earnings Call, Feb 27, 2024
Longeveron Reports Year-End 2023 Results and Provides Corporate Update
AQ
Longeveron Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Longeveron to Report Year-End 2023 Results and Provide Corporate Update February 27, 2024
AQ
Transcript : Longeveron Inc. - Shareholder/Analyst Call
Longeveron Receives Notice of United States Patent Allowance for the Technology Behind its Lead Investigation Product Lomecel-B™
AQ
Longeveron Receives Notice of United States Patent Allowance for the Technology Behind Its Lead Investigation Product Lomecel-B
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LGVN Stock
  4. News Longeveron Inc.